Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome.
暂无分享,去创建一个
E. Lacivita | M. Leopoldo | M. Ragozzino | Mauro Niso | J. Desaphy | C. Altamura | L. Ciranna | L. Costa | M. L. Stama | Anna L. Arzuaga